Bifurcation ABSORB OCT Trial (BISORB OCT)
Sponsor: Abbott Medical Devices
This NA trial investigates Arterial Occlusive Lesions and Arteriosclerosis and is currently ongoing. Abbott Medical Devices leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Apr 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Feb 2019 — Apr 2020 [monthly]
Active Not Recruiting NA
▶ Show 5 earlier versions
-
Dec 2018 — Feb 2019 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Feb 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
- J.J. Wykrzykowska
For direct contact, visit the study record on ClinicalTrials.gov .